Rentokil
167 hedge funds and large institutions have $1.63B invested in Rentokil in 2022 Q4 according to their latest regulatory filings, with 167 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2.1% more ownership
Funds ownership: 0% → 2.1% (+2.1%)
100% less call options, than puts
Call options by funds: $93K | Put options by funds: $23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$514M |
| 2 |
GCM
Gates Capital Management
New York
|
+$162M |
| 3 |
Morgan Stanley
New York
|
+$87.8M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$81.9M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$80.4M |
Top Sellers
RTO Hedge Fund Activity: Q4 2022 in Review
167 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q4 2022, worth a combined $1.63B.
Buyers outnumbered sellers: 167 funds opened new RTO positions and 0 closed out — a net gain of 167 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $514M.
- 167 institutional investors held Rentokil (RTO) as of Q4 2022, up from 0 in Q3 2022.
- Funds reported $1.63B of Rentokil stock for Q4 2022.
- 167 funds opened new Rentokil positions in Q4 2022 and 0 closed out, a net change of +167 holders.
- The largest Rentokil buyer in Q4 2022 was Janus Henderson Group, an estimated $514M added.
Based on aggregated 13F filings for Q4 2022.